Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Blann

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|December 10, 1997
Assessment of endothelial function using plasma markersA Blann, G Lip
Thrombosis Research|June 1, 1992
Von Willebrand factor, angiotensin converting enzyme and endothelial cell damage in veno-occlusive disease and bone marrow transplantationA Blann, P Collins
Cardiovascular Research|May 1, 1997
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?G Y Lip, A Blann
Atherosclerosis|August 26, 1998
von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosityA Blann, A Bignell, C McCollum
Atherosclerosis|October 25, 1996
Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectinA Blann, J Morris, C McCollum
Blood|February 5, 2000
Circulating endothelial cells in acute coronary syndromesF Dignat-George, A Blann, J Sampol
Lancet (London, England)|October 22, 1994
Endothelial cell harbingers of adult respiratory distress syndrome in acute pancreatitisC Chaloner, A Blann, J M Braganza
Lancet (London, England)|November 5, 1997
Chronic infections and coronary heart diseaseJ Constans, M Seigneur, A Blann, et al.
British Journal of Haematology|October 16, 1999
Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0A Blann, J Hewitt, F Siddiqui, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 11, 2009
Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA)A S Arunkalaivanan, A Morrison, S Jha, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|December 10, 1997
Assessment of endothelial function using plasma markersA Blann, G Lip
Thrombosis Research|June 1, 1992
Von Willebrand factor, angiotensin converting enzyme and endothelial cell damage in veno-occlusive disease and bone marrow transplantationA Blann, P Collins
Cardiovascular Research|May 1, 1997
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?G Y Lip, A Blann
Atherosclerosis|August 26, 1998
von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosityA Blann, A Bignell, C McCollum
Atherosclerosis|October 25, 1996
Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectinA Blann, J Morris, C McCollum
Blood|February 5, 2000
Circulating endothelial cells in acute coronary syndromesF Dignat-George, A Blann, J Sampol
Lancet (London, England)|October 22, 1994
Endothelial cell harbingers of adult respiratory distress syndrome in acute pancreatitisC Chaloner, A Blann, J M Braganza
Lancet (London, England)|November 5, 1997
Chronic infections and coronary heart diseaseJ Constans, M Seigneur, A Blann, et al.
British Journal of Haematology|October 16, 1999
Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0A Blann, J Hewitt, F Siddiqui, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 11, 2009
Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA)A S Arunkalaivanan, A Morrison, S Jha, et al.
Pageof 5